Thomson CenterWatch Publishes 2006 Edition of State of Clinical Trials Industry
BOSTON, MA – May 1, 2006 – Thomson CenterWatch, a global publishing and information services company focused on clinical trials market research, releases its second annual edition of the top-selling sourcebook, State of the Clinical Trials Industry.
This 398-page book features the latest market intelligence data and news briefs analyzing the clinical research market and has been reorganized for ease-of-use with an index and an expanded table of contents.
The 2006 edition also boasts 150 new charts, many featuring proprietary CenterWatch data, hundreds of updated charts, disease profiles with pipeline information, and a review of the top clinical research stories of 2005 as reported by the editorial staff of The CenterWatch Monthly. Much of the data is based on CenterWatch's clinical research benchmarking surveys conducted across global segments and represents an analysis of current sponsor and clinical research organization (CRO) practices.
"Each year with our release of a new edition of State of the Clinical Trials Industry, clinical researchers, biotech and pharmaceutical executives, CRO executives, and investment analysts look forward to using the new data charts in it for their own presentations–or for tracking the changes in the industry," said Dr. Mary Jo Lamberti, senior manager of Market Research at Thomson CenterWatch.
State of the Clinical Trials industry presents the following data highlights:
- Worldwide and U.S. industry sales
- Top 10 pharma and biotech R&D spends
- Worldwide drugs in development by top therapeutic area
- Trial success based on company size
- CRO market size, costs, and performance
- Regulatory submissions and approvals
- Patient recruitment and retention issues
About Thomson CenterWatch
Thomson CenterWatch–a business of the Thomson Corporation–is a Boston–based publishing and information services company that focuses on the clinical trials industry. We provide a variety of publications and information services used by pharmaceutical and biotechnology companies, CROs, SMOs and investigative sites involved in the management and conduct of clinical trials. We are also a key part of Thomson Clinical Trial Solutions, integrating powerful services with Medstat, NexCura and New England IRB offering sponsors and CROs a streamlined solution for clinical trial planning, conducting and post-study needs.
For a comprehensive listing and detailed information about our publications and services, please visit our web site at www.centerwatch.com. You can also contact us at (866) 219-3440 for subscription and order information. technology, enhance the penetration, message impact and value of the extensive NCERx platform.